Our platform specializes in molecular profiling for cancer to better understand tumor behavior and guide treatment selection. By analyzing genetic and molecular markers, we support personalized cancer medicine approaches that improve precision. This allows clinicians to consider targeted chemotherapy, immunotherapy for TNBC, and advanced therapeutic options tailored to each patient. https://tnbc.envita.com/